Article Information
History
- November 18, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Peter Jeon1,2,
- Roberto Limongi3,
- Sabrina D. Ford3,4,
- Cassandra Branco4,
- Michael Mackinley3,5,
- Maya Gupta6,
- Laura Powe4,
- Jean Théberge1,2,4,7,8 and
- Lena Palaniyappan1,2,3,4,*
- 1Department of Medical Biophysics, Western University, London, Canada
- 2Lawson Health Research Institute, Imaging Division, London, Canada
- 3Robarts Research Institute, Western University, London, Canada
- 4Department of Psychiatry, Western University, London, Canada
- 5Department of Neuroscience, Western University, London, Canada
- 6Department of Psychology, Western University, London, Canada
- 7St. Joseph’s Health Care, Diagnostic Imaging, London, Canada
- 8Department of Medical Imaging, Western University, London, Canada
- ↵*Correspondence:
Lena Palaniyappan, Robarts Research Institute, 1151 Richmond Street N., Room 3208, UWO, London, Ontario, Canada, N6A 5B7, Telephone:
(519) 931-5777 (ext. 24398), Email:
lpalaniy{at}uwo.ca
Posted November 18, 2020.
Glutathione as a molecular marker of functional impairment in patients with at-risk mental state: 7-Tesla 1H-MRS study
